Restart Life Sciences Corp. (HEAL.CX)
0.07
0.00 (0.00%)
CAD |
CNSX |
Oct 23, 16:00
Restart Life Sciences Net Income (Quarterly) : -1.017M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.017M |
| March 31, 2026 | -0.3261M |
| December 31, 2025 | -0.1573M |
| September 30, 2025 | -0.211M |
| June 30, 2025 | -0.2035M |
| March 31, 2025 | -0.8188M |
| December 31, 2024 | 0.0001M |
| September 30, 2024 | 0.4596M |
| June 30, 2024 | -0.0906M |
| March 31, 2024 | -0.1444M |
| December 31, 2023 | -0.2096M |
| September 30, 2023 | -0.1841M |
| June 30, 2023 | -0.3028M |
| March 31, 2023 | -0.528M |
| December 31, 2022 | -1.069M |
| September 30, 2022 | -0.4029M |
| June 30, 2022 | -0.3668M |
| March 31, 2022 | -0.6269M |
| December 31, 2021 | -0.2436M |
| September 30, 2021 | -1.403M |
| June 30, 2021 | -0.421M |
| March 31, 2021 | -0.6169M |
| December 31, 2020 | -16.09M |
| September 30, 2020 | -0.5545M |
| June 30, 2020 | -6.425M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1838M |
| December 31, 2019 | -0.2505M |
| September 30, 2019 | -0.3439M |
| June 30, 2019 | -0.4705M |
| March 31, 2019 | -0.3331M |
| December 31, 2018 | -0.5497M |
| September 30, 2018 | -0.7554M |
| June 30, 2018 | -0.1947M |
| March 31, 2018 | -2.073M |
| December 31, 2017 | -0.7966M |
| September 30, 2017 | -0.4682M |
| June 30, 2017 | -0.3348M |
| March 31, 2017 | -0.2662M |
| December 31, 2016 | -1.598M |
| September 30, 2016 | -0.1941M |
| June 30, 2016 | -0.1982M |
| March 31, 2016 | -0.0852M |
| December 31, 2015 | -0.2393M |
| September 30, 2015 | -0.1709M |
| June 30, 2015 | -0.1113M |
| March 31, 2015 | -0.1677M |
| December 31, 2014 | -1.736M |
| September 30, 2014 | -0.119M |
| June 30, 2014 | -0.1331M |
| March 31, 2014 | -0.0725M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Spectral Medical, Inc. | 0.331M |
| Resverlogix Corp. | -8.421M |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | -0.2796M |
| Defence Therapeutics Inc | -2.962M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.3312M |
| Total Expenses (Quarterly) | 1.348M |
| EPS Diluted (Quarterly) | -0.0167 |
| Enterprise Value | 3.951M |
| Gross Profit Margin (Quarterly) | -213.3% |
| Profit Margin (Quarterly) | -307.0% |
| Earnings Yield | -44.86% |
| Normalized Earnings Yield | -46.29 |